Cite

HARVARD Citation

    Vergnenegre, A. et al. (2013). Treatment of lung cancer: will financial issues become a criterion of choice?. Expert review of pharmacoeconomics & outcomes research. pp. 273-275. [Online]. 
  
Back to record